Related by context. All words. (Click for frequent words.) 73 Urocidin TM 71 YONDELIS 71 Phase IIb clinical trials 71 StemEx R 70 OvaRex ® MAb 70 Vectibix panitumumab 70 Amrubicin 70 oral ridaforolimus 69 Fodosine 69 acyclovir Lauriad R 69 JAK inhibitor 69 Aplidin 69 Allovectin 7 69 BLA filing 69 phase IIa clinical 69 HuMax CD4 69 Civacir 69 Troxatyl 69 OvaRex R 69 Loramyc R 69 OncoVEX 69 Phase IIIb clinical 69 phase IIb clinical 69 PDE4 inhibitor 68 reslizumab 68 tolevamer 68 ruxolitinib 68 tremelimumab 68 deforolimus 68 Phase Ib study 68 Archexin 68 Proxinium TM 68 Q#IR 68 RhuDex ® 68 ELACYT 68 BrachySil 68 Ketotransdel 68 CDP# 68 alvespimycin 68 faropenem 68 PrevOnco ™ 67 UPLYSO 67 pharmacokinetic PK study 67 registrational 67 Onconase 67 BrachySil TM 67 ganetespib 67 apaziquone 67 Phase III TRIST 67 Velcade bortezomib 67 forodesine 67 Phase Ib II 67 EOquin TM 67 personalized immunotherapy 67 Erbitux cetuximab 67 Cellegesic 67 cancer immunotherapies 67 Alvesco R 67 Zemplar Capsules 67 Panzem R NCD 67 phase Ib 67 oral salmon calcitonin 67 LHRH antagonist 67 Troxatyl TM 67 Allovectin 7 R 67 Phase #b/#a clinical 67 Telatinib 67 Ixempra 67 PSMA ADC 67 lumiliximab 67 IV Busulfex 66 IL# PE#QQR 66 LEVADEX ™ 66 multicenter Phase II 66 ospemifene 66 Firazyr 66 immunotherapeutic vaccine 66 oral deforolimus 66 Virulizin ® 66 PHX# 66 Phase Ib 66 PrevOnco 66 phase IIa 66 TBC# 66 GALNS 66 regorafenib 66 phase IIb 66 Gleevec imatinib mesylate 66 ixabepilone 66 StemEx 66 PREOS R 66 Silodosin 66 Tarceva TM 66 Evoltra 66 PANVAC VF 66 inhaled AAT 66 phase IIb trial 66 vidofludimus 66 PEGylated interferon 66 eniluracil 66 Genasense ® 66 OncoVex 66 Simulect 66 Nexavar ® 66 Myocet 66 OncoVEX GM CSF 66 CVac 66 bardoxolone 66 MAGE A3 ASCI 66 Cloretazine ® 66 lomitapide 66 Onco TCS 66 GLPG# 66 Phase Ib clinical 66 histamine dihydrochloride 66 Shigamabs ® 66 Targretin capsules 66 BEMA Fentanyl 66 MyVax 66 Xinlay 66 Phase IIa trials 66 Phase 2b clinical trials 66 Phase #b/#a 66 IMA# 66 ThermoDox R 66 Fibrillex 65 orBec 65 BEMA TM Fentanyl 65 Pazopanib 65 dalbavancin 65 successfully commercialize Iluvien 65 elacytarabine 65 Zybrestat 65 ZACTIMA 65 Alferon N 65 Pennsaid R 65 Allovectin 7 ® 65 mertansine 65 pain palliation 65 SNT MC# 65 torezolid phosphate 65 concurrent chemoradiation 65 Vicinium TM 65 Mipomersen 65 ASONEP 65 Trastuzumab DM1 65 proteasome inhibitor 65 Ceflatonin 65 farletuzumab 65 elotuzumab 65 Evoltra ® 65 Uplyso 65 tanespimycin 65 obatoclax 65 L BLP# 65 BRIM2 65 Frova ® 65 HuMax TAC 65 Xanafide 65 Capesaris 65 HuMax EGFr 65 ZEVALIN ® 65 GLP toxicology studies 65 PREOS 65 Virulizin R 65 tramiprosate Alzhemed TM 65 immatics 65 liposomal formulation 65 SUTENT ® 65 TRISENOX 65 vosaroxin 65 CIP TRAMADOL ER 65 Spiegelmer ® 65 Cx# [002] 65 CRD5 65 oral taxane 65 Tesmilifene 65 budesonide foam 65 liprotamase 65 Phase III 65 voclosporin 65 BRAF inhibitor 65 CR# vcMMAE 65 TOCOSOL Paclitaxel 65 MAA submission 65 rhIGF-I/rhIGFBP-3 65 novel oral anticoagulant 65 Phase IIb trials 65 Alzhemed TM 65 ATL# [001] 65 RhuDex 64 HepeX B 64 Daclizumab 64 Urokinase 64 cathepsin K inhibitor 64 Specifid 64 lorvotuzumab mertansine 64 midstage trials 64 ONCONASE R 64 GRNVAC1 64 Traficet EN 64 Asentar 64 pradefovir 64 seliciclib CYC# 64 Cloretazine 64 Annamycin 64 sorafenib tablets 64 Solazed 64 EGS# 64 BAY #-# 64 Trovax 64 BEXXAR 64 sunitinib malate 64 radiation sensitizer 64 OvaRex 64 OHR/AVR# 64 Temsirolimus 64 ReN# 64 Octreolin 64 IND submission 64 rhThrombin 64 Personalized Immunotherapy 64 Augment Injectable 64 MOZOBIL 64 triphendiol 64 Zelrix 64 VALSTAR 64 targeted radiotherapeutic 64 IIa trial 64 Surfaxin LS 64 MAXY G# 64 ThGRF 64 Dacogen injection 64 Nexavar sorafenib 64 methylnaltrexone 64 SinuNase ™ 64 TASQ 64 Evoltra TM 64 Gattex 64 Neuradiab 64 Arzerra ofatumumab 64 DXL# 64 Oasmia 64 GVAX R 64 generation purine nucleoside 64 Fentanyl TAIFUN R 64 amrubicin 64 confirmatory Phase III 64 OLEPTRO 64 Teysuno 64 WILEX 64 oral antiviral 64 vinflunine 64 Pertuzumab 64 trastuzumab DM1 64 VNP#M 64 CEQ# 64 Oncogenex 64 Phase 2b trial 64 Bezielle 64 isavuconazole 64 Neovastat 64 BST CarGel R 64 Factor VIIa 64 EOquin 64 Harry Palmin President 64 Tykerb lapatinib 64 Degarelix 64 Trofex 64 ridaforolimus 64 DPX Survivac 64 Panzem R 64 Pruvel 64 Corlux 64 atacicept 64 trastuzumab DM1 T DM1 64 Omapro 64 Preos 64 Phase lll 64 Retacrit 64 metastatic hormone refractory 64 candidate TNFerade biologic 64 Taxotere docetaxel 64 NP2 Enkephalin 64 indibulin 64 EndoTAG TM -1 64 RIGScan CR 64 IRX 2 64 RhuDex R 64 VersaFilm 64 ITAX 64 Valtropin 64 Theratope 64 Chemophase 64 Azedra 64 Fibrin Pad 64 ularitide 64 Phase III randomized controlled 64 midstage clinical 64 Loramyc 64 tezampanel NGX# 64 Genz # 64 glucokinase activator 64 galiximab 64 TEMODAL 64 Orazol 64 oral PTH 64 Insegia 64 anticancer compound 64 Phase #/#a 64 Folotyn 64 Nebido 64 Viramidine 64 Rezular 64 GLP1 agonist 64 PROSTVAC TM 63 omacetaxine mepesuccinate 63 Liprostin 63 custirsen 63 Zolinza 63 EndoTAGTM 1 63 Jevtana 63 Acapodene 63 Saforis 63 Anturol TM 63 Clolar ® 63 Omnitarg 63 NEBIDO 63 dirucotide 63 Crofelemer 63 Emezine 63 Lumacan 63 Panzem 63 Zenapax 63 GVAX 63 Cethrin 63 Japanese Encephalitis vaccine 63 Fentanyl Taifun 63 oral methylnaltrexone 63 RhuDex TM 63 DCVax R 63 herpetic keratitis 63 Phase 2a clinical trials 63 LEUKINE 63 KNS # 63 CCR5 inhibitor 63 CytoFabTM 63 OMP #M# 63 dose escalation Phase 63 Phase 1b clinical 63 Onalta ™ 63 EpiCeram 63 Combidex 63 Voraxaze 63 Phenoptin 63 Irinotecan 63 LAS# [002] 63 registrational trial 63 ToGA 63 CIP ISOTRETINOIN 63 EFAPROXYN 63 Octreotide 63 bazedoxifene 63 talactoferrin 63 SCIB1 63 Zavesca r 63 Proquin XR 63 AEG# 63 Phase IIB 63 oral prodrug 63 AQ4N 63 Virulizin 63 MAXY VII 63 Certican 63 Mepact 63 ozarelix 63 RSR# 63 Shigamabs R 63 GVAX ® 63 pivotal bioequivalence 63 Revlimid lenalidomide 63 Oglemilast 63 oral fludarabine 63 Bayer Onyx 63 QRxPharma 63 Hedgehog antagonist 63 Aryplase 63 HGS# 63 metastatic castrate resistant 63 Argatroban 63 AeroLEF TM 63 MyVax personalized immunotherapy 63 recurrent metastatic 63 SUCCEED trial 63 Phase 1b trial 63 NVA# 63 drug GAP #B# 63 DCVax Brain 63 Marqibo TM 63 receptor tyrosine kinase inhibitor 63 Lupuzor 63 PF # [002] 63 huC# DM4 63 Abiraterone acetate 63 rindopepimut 63 miconazole Lauriad ® 63 thetreatment 63 PSN# [001] 63 refractory APL 63 Squalamine 63 midstage clinical trials 63 Amigal 63 phase IIb study 63 crofelemer 63 HuMax CD# 63 outlicensing 63 PROCHYMAL 63 gemcitabine Gemzar ® 63 incyclinide 63 Glybera R 63 Somatuline R Autogel R 63 OMAPRO 63 PI3K/Akt pathway inhibitor 63 relapsed MM 63 PEG SN# 63 DCVax ® Brain 63 Intravenous CP 63 Intraject 63 Alocrest 63 rNAPc2 63 Erbitux ImClone 63 G#DT 63 MAXY alpha 63 ACAPODENE 63 INCB# [001] 63 Proellex TM 63 ONCONASE 63 rALLy trial 63 volociximab 63 LEVADEX TM 63 OMAPRO ™ 63 Phase IIa trial 63 novel therapeutic antibodies 63 BrachySil ™ 63 OncoGel 63 Elagolix 63 Vandetanib 63 MOVIPREP R 63 Aflibercept 63 TransMID 63 Oxaliplatin 63 Plenaxis 63 Reverset 63 paclitaxel poliglumex 63 SYCREST 63 FluINsure 63 GV# [001] 63 Raptiva ® 63 LibiGel ® 63 Phase III clinical 63 CINTREDEKIN BESUDOTOX 63 Lucanix R 63 injectable formulations 63 ARIKACE ™ 63 terlipressin 63 investigational therapies 63 Egrifta 63 IV APAP 63 daclizumab 63 Icatibant 63 tesmilifene 63 Urocidin ™ 63 DR Cysteamine 63 outlicensed 63 CRMD# 63 Anthim 63 TroVax 63 DIFICID 63 Campath alemtuzumab 63 CAELYX 63 Pacira 63 Neuvenge 63 Diamyd ® 63 PROVENGE ® 63 bosutinib 63 Ozarelix 63 cannabinor 63 BRIM3 63 NEBIDO R 63 Toraymyxin TM 63 Omigard 63 MVA BN R 63 IMC #B 63 Ambrisentan 63 Pradefovir 63 Bicifadine 62 Loramyc ® 62 biologic therapy 62 Glassia 62 BLA submission 62 Rapinyl 62 HQK 62 IMC A# 62 FOLOTYN ® 62 docetaxel Taxotere ® 62 Nabi HB Intravenous 62 Evoltra R 62 Laquinimod 62 Fortical R 62 Medidur FA 62 PhG alpha 1 62 mitogen activated ERK kinase 62 pitavastatin 62 Hexvix 62 Dacogen decitabine 62 midstage studies 62 enzastaurin 62 Tamibarotene 62 DEB# 62 Phase Ib IIa 62 Campath ® 62 multi kinase inhibitor 62 selective androgen receptor modulator 62 axitinib 62 Altastaph 62 samalizumab 62 Flutiform TM 62 REMUNE R 62 clofarabine 62 rhFVIIa 62 BNC# 62 otelixizumab 62 superficial bladder cancer 62 Votrient 62 ABRAXANE ® 62 PDX pralatrexate 62 afamelanotide 62 Advagraf 62 inhaled antibiotic 62 Rescula 62 Orathecin 62 sargramostim 62 sorafenib Nexavar 62 panitumumab 62 CytoFab 62 Preotact 62 Multiferon R 62 radiotherapeutic 62 octreotide implant 62 topical NSAID 62 Reolysin 62 Torisel 62 fostamatinib 62 relapsed multiple myeloma 62 pomalidomide 62 Elocalcitol 62 LCP AtorFen 62 pediatric acute lymphoblastic 62 Plenaxis TM 62 Mycograb 62 oral anticancer 62 Phase III pivotal 62 Panzem NCD 62 antibody MAb 62 Cimzia TM 62 ATG Fresenius S 62 therapeutic monoclonal antibody 62 Bellicum 62 TransMID TM 62 Plenaxis R 62 Iluvien ® 62 SIR Spheres 62 Restanza 62 EDEMA3 62 GAP #B# 62 Vascugel 62 Zirgan 62 danoprevir 62 RIGScan 62 HCD# [002] 62 LymphoStat B TM 62 Somatuline Depot 62 pexiganan 62 Phase 2b study 62 oral rivaroxaban 62 multicenter Phase III 62 GRN# 62 TheraCIM 62 Ganciclovir 62 FavId 62 Phase III trials 62 Zingo TM 62 gepirone ER 62 aurora kinase 62 Marqibo 62 Dermylex TM 62 Pivotal Phase III 62 Manja Bouman CEO 62 FM VP4 62 nalbuphine ER 62 AzaSite Plus 62 corticosteroid dexamethasone 62 Goserelin 62 EndoTAG 62 humanised monoclonal antibody 62 BCR ABL inhibitor 62 Nipent R 62 Ziopharm 62 Kynapid 62 apricitabine ATC 62 Nanobody 62 Arranon 62 rilonacept 62 Clavis Pharma 62 ofatumumab 62 AZILECT ® 62 beta 1a 62 relapsing remitting MS RRMS 62 LBH# 62 BLP# Liposome Vaccine 62 SEASONIQUE 62 Phase Ib clinical trials 62 TRIST study 62 Solorel 62 TREANDA 62 EP #R 62 CCR5 antagonist 62 Zytiga 62 rALLy clinical trial 62 Phase IIa clinical trials 62 EnzymeRx 62 vemurafenib 62 Arzerra TM 62 belinostat 62 talabostat 62 Dynepo 62 Dual Opioid 62 Abstral 62 Vaccinex 62 Instanyl 62 Raptiva R 62 elvucitabine 62 initiated Phase Ib 62 Darusentan 62 Bonefos 62 acyclovir Lauriad ® 62 commercialize elagolix 62 SinuNase TM 62 immunotherapeutic agent 62 HepaGam B 62 Angiocept 62 Pfizer Sutent 62 phase 2a 62 Excellagen 62 LymphoStat B belimumab 62 POSIDUR TM 62 Phase IIb III 62 Generx ™ 62 CureTech 62 Fludara ® 62 Diamyd R 62 Exherin TM 62 Fibrillex TM 62 CoFactor 62 YONDELIS R 62 Exherin 62 BAL# [002] 62 IoGen 62 Dyloject TM 62 Dalbavancin 62 Sanvar R 62 ColorectAlert TM 62 BioNumerik 62 Viprinex 62 Roche Xeloda 62 ThermoDox ® 62 Nicole Onetto MD 62 Angioblast 62 Onsolis 62 NeoDisc 62 Phase Ia 62 SuperAntibody 62 Desmoteplase 62 registrational studies 62 Tesetaxel 62 Bayer Nexavar 62 USL# 62 Dextofisopam 62 alemtuzumab Campath 62 drug ISA# 62 Aloxi injection 62 AKT inhibitor 62 SEPET TM 62 DEEP AF 62 NEUMUNE 62 maribavir 62 ELND# 62 candidates Dyloject TM 62 ELIQUIS 62 bendamustine 62 Glufosfamide 62 Bendamustine 62 Gamida Cell 62 Exelixis compounds 62 Xifaxan rifaximin 62 PD LID 62 Cinquil 62 Alpharadin 62 MGCD# [001] 62 cetuximab Erbitux 62 rasagiline tablets 62 miconazole Lauriad 62 Scancell 62 rituximab Rituxan 62 Multiferon 62 Arikace 62 TRANSDUR Bupivacaine 62 HDL Selective Delipidation 62 oral calcitonin 62 MDS AML 62 Cethrin R 62 Phospha E 62 Hycamtin 62 sumatriptan injection 62 Dabigatran etexilate 62 CytoFab ™ 62 TASKi3 62 Cancidas 62 Phase 2b clinical 62 luliconazole 62 Targeted Chemotherapy 62 BCR ABL inhibitors 62 pralatrexate 62 Fx #A 62 EVIZON TM 62 EndoTAG TM 62 docetaxel Taxotere R 62 ZADAXIN ® 62 anti CD3 monoclonal 62 glufosfamide 62 thymalfasin 62 Ramoplanin 62 Davanat 62 MGd 62 PNP inhibitor 62 ulimorelin 62 investigational antiplatelet agent 61 Benlysta belimumab 61 Solasia 61 Cleviprex TM clevidipine 61 CTAP# Capsules 61 Canvaxin TM 61 dirucotide MBP# 61 Vidaza R 61 Vernakalant 61 Pirfenidone 61 ZOLINZA 61 Anidulafungin 61 macitentan 61 Nuvion 61 BioVant 61 malignant ascites 61 endothelin antagonist 61 thalidomide Thalomid 61 Abiraterone 61 Memryte 61 trospium 61 TNFerade TM 61 GRALISE 61 Cetrorelix 61 rEV# 61 Dendreon Provenge 61 immunosuppressant therapies 61 autologous cellular immunotherapy 61 AMPK activators 61 Gelclair 61 Peginterferon alfa 2b 61 dextofisopam 61 RezularTM 61 ONCASPAR 61 hypoxia activated prodrug 61 relapsed ovarian cancer 61 therapeutic peptide 61 cystinosis patients 61 HCV antiviral 61 Xeloda ® 61 AP# [003] 61 Somatuline Autogel 61 Tofacitinib 61 AGGRASTAT ® 61 Phase 2a trial 61 immunotherapeutic 61 silodosin 61 INT# [002] 61 Tanespimycin 61 Balaglitazone 61 JAK2 inhibitor 61 valopicitabine 61 VivaGel ™ 61 tiapamil 61 tramiprosate ALZHEMED TM 61 HRPC 61 subcutaneous formulation 61 KIACTA ™ 61 Endeavor DES 61 aerosolized AAT 61 TELINTRA 61 MabThera rituximab 61 biliary tract cancer 61 AZILECT R 61 IGF 1R inhibitor 61 intravenous acetaminophen 61 Junovan 61 Orphan Drug designations 61 ATL# [002] 61 Phase IIa clinical 61 Immunotherapeutic 61 CIMZIA TM 61 Carfilzomib 61 Tavocept 61 Levoleucovorin 61 Behcet uveitis 61 Loramyc TM 61 metastatic sarcomas 61 Guanilib 61 Onrigin 61 MEK inhibitors 61 DU #b 61 BCG refractory 61 cangrelor 61 aleglitazar 61 Orphan Drug designation 61 Golimumab 61 OVATURE 61 TOCOSOL Camptothecin 61 XmAb# 61 HyperAcute 61 oral talactoferrin 61 Cimzia ® certolizumab pegol 61 satraplatin 61 Tocosol Paclitaxel 61 Plicera 61 oncolytic virus therapies 61 icatibant 61 indiplon capsules 61 PLK1 SNALP 61 CELVAPAN H#N# 61 JAK inhibitors 61 NeuVax 61 bortezomib Velcade 61 Omacetaxine 61 Zensana TM 61 temsirolimus 61 rolapitant 61 GVAX immunotherapy 61 Sopherion 61 Advexin 61 CAPHOSOL 61 NV1FGF 61 orphan designation 61 liver resection surgeries 61 valopicitabine NM# 61 Gamunex C 61 Mycamine 61 Viprinex TM 61 HGS ETR1 61 CHOP chemotherapy 61 Novolimus 61 Tracleer r 61 Sebivo 61 randomized Phase IIb 61 tubulin inhibitor 61 investigational humanized monoclonal antibody 61 Ferumoxytol 61 CIP Fenofibrate 61 CINQUIL 61 VitiGam 61 zalutumumab 61 MEK inhibitor 61 SinuNase 61 Zensana 61 ABILIFY ® 61 TG# [001] 61 Enjuvia 61 omacetaxine 61 intranasal formulation 61 rPA anthrax vaccine 61 Ceplene TM 61 LUCASSIN 61 Nanobody ® 61 refractory chronic lymphocytic 61 laninamivir 61 Cardio Vascu Grow 61 HER2 positive metastatic breast 61 preclinical toxicology 61 targeted antifolate 61 progressive metastatic prostate 61 abiraterone acetate 61 histone deacetylase inhibitor 61 Ereska 61 teriflunomide 61 IMVAMUNE R 61 compound INCB# 61 Kissei Pharmaceutical 61 OSMOPREP 61 Toctino ® alitretinoin 61 BCX# 61 Gabapentin GR 61 Fusilev 61 alvimopan 61 forodesine hydrochloride 61 Aclasta Reclast 61 MYDICAR ® 61 NSABP C 61 vascular disrupting agents 61 Soliris TM eculizumab 61 DCCR 61 Maxy G# 61 Removab 61 INTERCEPT platelets 61 REGEN trial 61 cediranib 61 BEMA Granisetron 61 GTC recombinant human 61 dacetuzumab 61 eTag assays 61 Ostarine 61 advanced metastatic prostate 61 LCP Tacro 61 miconazole Lauriad R 61 Abbokinase 61 molecular imaging radiopharmaceutical 61 Sym# 61 P#X# antagonist 61 PORxin TM 61 TroVax ® 61 Xcellerated T Cells 61 R sorafenib tablets 61 Litx 61 Pennsaid Plus 61 lintuzumab 61 Duromist ™ 61 ADVANCE PD 61 initiate Phase 1b 61 OMNARIS Nasal Spray 61 dexanabinol 61 Cetuximab Erbitux 61 balsalazide tablet 61 Everolimus 61 Celgene Revlimid 61 VEGF inhibitor 61 INCB# [002] 61 Hematide ™ peginesatide 61 hormone LHRH antagonist 61 Teflaro 61 Pyridorin 61 romidepsin 61 Ceflatonin R 61 FORTIS M trial 61 Collategene 61 MyVax R 61 Zerenex 61 dasatinib Sprycel 61 paclitaxel Taxol R 61 Arcalyst 61 Noxafil 61 RSD# oral 61 methylnaltrexone bromide 61 RECOTHROM R 61 GED aPC 61 acetonide FA 61 Xcytrin R 61 prGCD 61 PTK ZK 61 topical ophthalmic 61 Canvaxin 61 XYOTAX TM 61 TACI Ig 61 Æterna Zentaris 61 ZEFTERA TM Zevtera TM 61 Delcath PHP System 61 APEX PD 61 metastatic bladder 61 Androxal TM 61 ATryn ® 61 Vascular Wrap TM 61 Tarvacin TM 61 metaglidasen 61 cabozantinib 61 Vitaxin 61 CBLC# 61 randomized controlled Phase 61 Hepatocellular Carcinoma HCC 61 Pemetrexed 61 Afatinib 61 faropenem medoxomil 61 Aphthasol R 61 opioid induced bowel dysfunction 61 multiple myeloma MM